SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-283092
Filing Date
2011-10-27
Accepted
2011-10-27 07:35:35
Documents
3
Period of Report
2011-10-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d248374d8k.htm 8-K 12921
2 PRESS RELEASE d248374dex991.htm EX-99.1 71279
3 GRAPHIC g248374g48y31.jpg GRAPHIC 18628
  Complete submission text file 0001193125-11-283092.txt   111244
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34921 | Film No.: 111160340
SIC: 2834 Pharmaceutical Preparations